Trial Profile
Bilastine and inflammation: an explorative study in subjects affected by Parietaria J.-induced Rhinoconjunctivitis – The Bi-FLO study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2018
Price :
$35
*
At a glance
- Drugs Bilastine (Primary)
- Indications Rhinoconjunctivitis
- Focus Therapeutic Use
- Acronyms Bi-FLO study
- Sponsors Menarini
- 26 Feb 2018 New trial record